Blog
RSS FeedPosted by Michael Wonder on 05 Oct 2021
Medicare reverses course on decision to universally cover breakthrough medical devices for 4 years
4 October 2021 - In January 2021, in the waning days of the Trump Administration, the CMS finalised a rule ...
Posted by Michael Wonder on 05 Oct 2021
WHO prioritises access to diabetes and cancer treatments in new Essential Medicines Lists
1 October 2021 - High prices and low availability still a major barrier for patients’ access to new and old medicines. ...
Posted by Michael Wonder on 05 Oct 2021
Pharmaceutical industry backs workplace vaccinations
5 October 2021 - Medicines Australia strongly recommends full COVID-19 vaccinations for the health and safety and protection of all ...
Posted by Michael Wonder on 14 Sep 2021
MTAA supports call for future of private health summit
13 September 2021 - The Medical Technology Association of Australia (MTAA) today supported calls from AMA President, Dr Omar Khorshid, ...
Posted by Michael Wonder on 13 Sep 2021
TLV is commissioned to secure access to antibiotics
13 September 2021 - TLV, the Swedish Public Health Agency and the Medical Products Agency have been commissioned by the Government ...
Posted by Michael Wonder on 30 Aug 2021
Review of the National Medicines Policy – call for submissions
30 August 2021 - The National Medicines Policy Review Committee is now welcoming submissions to support the review of the National Medicines ...
Posted by Michael Wonder on 21 Aug 2021
Competition, consolidation and evolution in the pharmacy market
12 August 2021 - Implications for efforts to contain drug prices and spending. ...
Posted by Michael Wonder on 13 Aug 2021
Making vaccines available to other countries before offering domestic booster vaccinations
12 August 2021 - On July 8, 2021, Pfizer and BioNTech announced they would be seeking US and European authorisation ...
Posted by Michael Wonder on 03 Aug 2021
Don’t want a vaccine? Be prepared to pay more for insurance.
2 August 2021 - America’s Covid-19 vaccination rate is at around 60 percent, for ages twelve and up. ...
Posted by Michael Wonder on 03 Aug 2021
National Medicines Policy Review Committee and Terms of Reference
3 August 2021 - The National Medicines Policy has influenced a number of important strategies, frameworks and programs developed since ...
Posted by Michael Wonder on 02 Aug 2021
National Medicines Policy Review will be significant for all Australians
30 July 2021 - Medicines Australia is eager to be part of a significant moment in history for Australian health ...
Posted by Michael Wonder on 30 Jul 2021
Announcement of the National Medicines Policy Review Committee and Terms of Reference
30 August 2021 - The Minister for Health has established an Expert Advisory Committee to lead the Review of the National ...
Posted by Michael Wonder on 28 Jul 2021
PHARMAC releases drug wish-list to be more 'transparent' but advocates say it gives false hope
28 July 2021 - PHARMAC has for the first time released a list of all the drugs it wants to ...
Posted by Michael Wonder on 22 Jul 2021
NHS England unveils new Innovative Medicine Fund
21 July 2021 - NHS England has unveiled its new Innovative Medicines Fund, to ensure patients have early access to ...
Posted by Michael Wonder on 04 Jul 2021
ICER to test principle of fair access to fairly priced pharmaceuticals
2 July 2021 - The controversial approval last month by the FDA of Aduhelm (aducanumab) for patients with early-stage Alzheimer’s disease ...